Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × aldesleukin × Clear all

Sponsor

Conditions

Melanoma 46 Neoplasm Metastasis 19 Skin Neoplasms 14 Carcinoma, Renal Cell 13 Leukemia, Myeloid, Acute 11 Kidney Neoplasms 10 Leukemia 9 Neoplasms 7 Uterine Cervical Neoplasms 5 Lymphoma 5 Congenital Abnormalities 5 Breast Neoplasms 5 Ovarian Neoplasms 4 Neuroblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Vaginal Neoplasms 2 Penile Neoplasms 2 Papillomavirus Infections 2 Oropharyngeal Neoplasms 2 Melanoma, Experimental 2 Lymphoma, Mantle-Cell 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Erythroblastic, Acute 2 Brain Neoplasms 2

Interventions

Sorafenib 49 pembrolizumab 20 Nivolumab 18 Bevacizumab 16 Radiosurgery 15 Doxorubicin 12 lenvatinib 8 Erlotinib Hydrochloride 7 atezolizumab 6 Ramucirumab 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 cabozantinib 5 Radiofrequency Ablation 5 tislelizumab 4 Sunitinib 4 Ipilimumab 4 regorafenib 3 nintedanib 3 carotuximab 3 bavituximab 3 Ribavirin 3 Radiotherapy 3 Oxaliplatin 3 Mitomycin 3 Leucovorin 3 Fluorouracil 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡